For the year, West Pharmaceutical now expects adjusted per-share earnings of $6.65 to $6.85, up from a prior outlook of $6.15 to $6.35. The company raised its sales outlook to $3.04 billion to $3.06 ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

Driven Compound Is Winning Over Reviewers, Professionals, and Biohackers BOSTON, MASSACHUSETTS / ACCESS Newswire / July 17, ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...

Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.

With U.S. stock markets set to open in two hours, West Pharmaceutical Services Inc. (WST) was up 17.6% in pre-market trading, and Icon PLC (ICLR) was up 16.1%.